<DOC>
	<DOCNO>NCT02125513</DOCNO>
	<brief_summary>The purpose study define whether 6 course neoadjuvant chemotherapy lead higher rate complete cytoreductive surgery compare 3 course neoadjuvant chemotherapy patient epithelial ovarian cancer , fallopian tube cancer primary peritoneal cancer .</brief_summary>
	<brief_title>Neoadjuvant Chemotherapy Epithelial Ovarian Cancer</brief_title>
	<detailed_description />
	<mesh_term>Carcinoma</mesh_term>
	<mesh_term>Ovarian Neoplasms</mesh_term>
	<mesh_term>Neoplasms , Glandular Epithelial</mesh_term>
	<mesh_term>Fallopian Tube Neoplasms</mesh_term>
	<mesh_term>Paclitaxel</mesh_term>
	<mesh_term>Albumin-Bound Paclitaxel</mesh_term>
	<mesh_term>Carboplatin</mesh_term>
	<criteria>Female patient ≥18 year . Karnofsky Performance Scale ≥ 60 % Histologically confirm epithelial ovarian cancer , fallopian tube carcinoma primary peritoneal carcinoma exception mucinous , clear cell carcinosarcoma histology . Documented International Federation Gynecologic Oncology ( FIGO ) stage IIICIV unsuitable complete primary cytoreductive surgery . Inoperability must confirm open laparoscopy laparotomy . Adequate bone marrow , liver renal function receive chemotherapy subsequently undergo surgery : white blood cell &gt; 3,000/µL , absolute neutrophil count ≥1,500/µL , platelets ≥100,000/µL , hemoglobin ≥9 g/dL , serum creatinine &lt; 1.25 x upper normal limit ( UNL ) creatinine clearance ≥60 mL/min accord CockroftGault formula local lab measurement serum bilirubin &lt; 1.25 x UNL , AST ( SGOT ) ALT ( SGPT ) &lt; 2.5 x UNL . Signed informed consent obtain prior studyspecific procedure Mucinous , clear cell carcinosarcoma histology . Synchronous previous malignancy within 3 year prior start study treatment , exception adequately treat nonmelanomatous skin cancer carcinoma situ ( cervix breast site ) . Patients brain metastasis , seizure control standard medical therapy , history cerebrovascular accident ( CVA , stroke ) transient ischemic attack ( TIA ) subarachnoid hemorrhage within 6 month enrollment study . Any concurrent medical condition contraindicate surgery chemotherapy could compromise adherence protocol ( include limit impaired cardiac function clinically significant cardiac disease , active uncontrolled infection , HIVpositive patient antiretroviral therapy , uncontrolled diabetes , cirrhosis , chronic active persistent hepatitis , impaired respiratory function require oxygendependence , serious psychiatric disorder ) . Pregnant breastfeed woman .</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2014</verification_date>
	<keyword>neoadjuvant chemotherapy</keyword>
	<keyword>ovarian cancer</keyword>
	<keyword>fallopian tube carcinoma</keyword>
	<keyword>peritoneal carcinoma</keyword>
	<keyword>randomize study</keyword>
</DOC>